Chase Knickerbocker

Stock Analyst at Craig-Hallum

(1.15)
# 1830
Out of 5,218 analysts
31
Total ratings
52.63%
Success rate
12.18%
Average return
15 Stocks
Name Action Price Target Current % Upside Ratings Updated
scPharmaceuticals
Maintains: Buy
16 12
3.21 273.83% 2 Nov 14, 2024
KORU Medical Systems
Maintains: Strong Buy
4 5
4.26 17.37% 1 Nov 14, 2024
PolyPid
Initiates Coverage On: Buy
10
2.61 283.14% 1 Nov 4, 2024
Eton Pharmaceuticals
Maintains: Strong Buy
10 15
12.31 21.85% 3 Oct 28, 2024
Indivior
Maintains: Buy
20 16
11.6 37.93% 3 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 65
35.43 83.46% 3 Oct 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 8
n/a n/a 2 Sep 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 15
6.03 148.76% 4 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 10
3.52 184.09% 3 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 12
9.17 30.86% 2 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
7.32 36.61% 1 Jul 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
12.09 48.88% 1 Jun 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
10.4 121.15% 2 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
1 2
0.37 224.32% 2 Jul 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
7.87 166.84% 1 Mar 13, 2023